心房纤维颤动与睡眠呼吸障碍

Association of sleep-disordered breathing and atrial fibrillation

心房纤维颤动（简称房颤）是临床常见的心律失常，可明显降低患者生活质量，显著增加医疗费用。除男性、老龄、卒中、慢性心力衰竭、冠状动脉疾病之外，睡眠呼吸暂停也可增加房颤的发生或易患性。既往研究表明房颤患者阻塞性睡眠呼吸暂停的发病率较高，而近年研究显示，中枢性睡眠呼吸暂停的发生率也较高，尤其是伴中枢性睡眠呼吸暂停的陈施呼吸。睡眠呼吸障碍与房颤患者的不良预后密切相关，而良好管理睡眠呼吸障碍可改善房颤患者的预后、提高生活质量。

Atrial fibrillation （AF） is a common clincal supraventricular arrhythmia that increases in prevalence with male sex, increasing age and in the presence of comorbidities such as stoke, chronic heart failure （HF）, coronary artery disease and sleep apnea. As a result, the quality of life patients significantly decline, making AF a costly disease. Previous studies have confirmed that prevalence rates of obstructive sleepapnea （OSA） in patients with AF is increasing. Another group of sleep-related breathing disorders has recently attracted increasing attention in particular connection with cardiac diseases：central sleep apnea, especially the subtyle with Cheyne Stokes respiration （CSA/CSR）. Although the prevalence of central sleep apnea （CSA） in patients with AF is less well defined, the frequency of apneas can be reduced by effective treatment of AF. Strengthening Sleep-disordered breathing recognition and management strategies as part of AF management appears to have the potential to reduce the impact of this arrhythmia at both the individual and societal levels, and has been recognized as importantin recent guidelines.